BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32549236)

  • 1. Exploring the Mechanism of Flaccidoxide-13-Acetate in Suppressing Cell Metastasis of Hepatocellular Carcinoma.
    Wu YJ; Wei WC; Dai GF; Su JH; Tseng YH; Tsai TC
    Mar Drugs; 2020 Jun; 18(6):. PubMed ID: 32549236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flaccidoxide-13-Acetate Extracted from the Soft Coral Cladiella kashmani Reduces Human Bladder Cancer Cell Migration and Invasion through Reducing Activation of the FAK/PI3K/AKT/mTOR Signaling Pathway.
    Neoh CA; Wu WT; Dai GF; Su JH; Liu CI; Su TR; Wu YJ
    Molecules; 2017 Dec; 23(1):. PubMed ID: 29280977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11-epi-Sinulariolide acetate reduces cell migration and invasion of human hepatocellular carcinoma by reducing the activation of ERK1/2, p38MAPK and FAK/PI3K/AKT/mTOR signaling pathways.
    Lin JJ; Su JH; Tsai CC; Chen YJ; Liao MH; Wu YJ
    Mar Drugs; 2014 Sep; 12(9):4783-98. PubMed ID: 25222667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flaccidoxide-13-Acetate-Induced Apoptosis in Human Bladder Cancer Cells is through Activation of p38/JNK, Mitochondrial Dysfunction, and Endoplasmic Reticulum Stress Regulated Pathway.
    Wu YJ; Su TR; Dai GF; Su JH; Liu CI
    Mar Drugs; 2019 May; 17(5):. PubMed ID: 31086026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sinulariolide Suppresses Human Hepatocellular Carcinoma Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 through MAPKs and PI3K/Akt Signaling Pathways.
    Wu YJ; Neoh CA; Tsao CY; Su JH; Li HH
    Int J Mol Sci; 2015 Jul; 16(7):16469-82. PubMed ID: 26204832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bornyl
    Yang TY; Wu ML; Chang CI; Liu CI; Cheng TC; Wu YJ
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
    Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY
    Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of pelitinib in the regulation of migration and invasion of hepatocellular carcinoma cells via inhibition of Twist1.
    Lee S; Kang E; Lee U; Cho S
    BMC Cancer; 2023 Jul; 23(1):703. PubMed ID: 37495969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternol inhibits migration and invasion of human hepatocellular carcinoma cells by targeting epithelial-to-mesenchymal transition.
    Zhu XL; Wang YL; Chen JP; Duan LL; Cong PF; Qu YC; Li-Ling J; Zhang MX
    Tumour Biol; 2014 Feb; 35(2):1627-35. PubMed ID: 24078466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP-2 and MMP-9.
    Liu J; Wen X; Liu B; Zhang Q; Zhang J; Miao H; Zhu R
    Mol Med Rep; 2016 Mar; 13(3):2401-8. PubMed ID: 26847170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cetyltrimethylammonium Bromide Disrupts the Mesenchymal Characteristics of HA22T/VGH Cells
    Yue CH; Chen CH; Lee WT; Su TF; Pan YR; Chen YP; Huang FM; Lee CJ
    Anticancer Res; 2020 Aug; 40(8):4513-4522. PubMed ID: 32727781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of PI3K/AKT/mTOR Signaling Pathway on Regulating and Controlling the Anti-Invasion and Metastasis of Hepatoma Cells by Bufalin.
    Sheng X; Zhu P; Zhao Y; Zhang J; Li H; Zhao H; Qin J
    Recent Pat Anticancer Drug Discov; 2021; 16(1):54-65. PubMed ID: 33530915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression.
    Ha TY; Hwang S; Moon KM; Won YJ; Song GW; Kim N; Tak E; Ryoo BY; Hong HN
    Anticancer Res; 2015 Apr; 35(4):1967-76. PubMed ID: 25862849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sinulariolide Inhibits Gastric Cancer Cell Migration and Invasion through Downregulation of the EMT Process and Suppression of FAK/PI3K/AKT/mTOR and MAPKs Signaling Pathways.
    Wu YJ; Lin SH; Din ZH; Su JH; Liu CI
    Mar Drugs; 2019 Nov; 17(12):. PubMed ID: 31783709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cinobufacini inhibits epithelial-mesenchymal transition of human hepatocellular carcinoma cells through c-Met/ERK signaling pathway.
    Qi F; Wang J; Zhao L; Cai P; Tang W; Wang Z
    Biosci Trends; 2018 Jul; 12(3):291-297. PubMed ID: 29794405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akebia trifoliata (Thunb.) Koidz Seed Extract inhibits human hepatocellular carcinoma cell migration and invasion in vitro.
    Lu WL; Yang T; Song QJ; Fang ZQ; Pan ZQ; Liang C; Jia DW; Peng PK
    J Ethnopharmacol; 2019 Apr; 234():204-215. PubMed ID: 30528882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sinulariolide Suppresses Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase through the PI3K/AKT/mTOR Signaling Pathway in Human Bladder Cancer Cells.
    Cheng TC; Din ZH; Su JH; Wu YJ; Liu CI
    Mar Drugs; 2017 Aug; 15(8):. PubMed ID: 28767067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells.
    Dong J; Zhai B; Sun W; Hu F; Cheng H; Xu J
    PLoS One; 2017; 12(9):e0185088. PubMed ID: 28934275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
    Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W
    Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.